Inventor · disambiguated record
Valerio Berdini
Also filed as: BERDINI VALERIO
45 granted patents·18 pending applications·548 citations·filing 2002–2023
98Inventor score
Files withASTEX THERAPEUTICS LTD34BERDINI VALERIO11SAXTY GORDON9OTSUKA PHARMA CO LTD4ALLEGRETTI MARCELLO1
Top patents by PatentIndex Score
63 records- 0195US9850228B2Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2016·Granted Dec 26, 2017·17 cites·5 claims
- 0295US9464071B2Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2014·Granted Oct 11, 2016·24 cites·45 claims
- 0395US9447098B2Pteridines as FGFR inhibitorsASTEX THERAPEUTICS LTD·Filed 2013·Granted Sep 20, 2016·35 cites·20 claims
- 0495US7385059B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsASTEX THERAPEUTICS LTD·Filed 2006·Granted Jun 10, 2008·33 cites·20 claims
- 0594US9309242B2Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2012·Granted Apr 12, 2016·26 cites·28 claims
- 0694US9303029B2Substituted quinoxalines as FGFR kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2012·Granted Apr 5, 2016·25 cites·20 claims
- 0794US8895601B2Pyrazolyl quinoxaline kinase inhibitorsSAXTY GORDON·Filed 2011·Granted Nov 25, 2014·25 cites·36 claims
- 0894US8399442B2Pharmaceutical compoundsBERDINI VALERIO·Filed 2006·Granted Mar 19, 2013·62 cites·26 claims
- 0993US9856236B2Substituted quinoxalines as FGFR kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2015·Granted Jan 2, 2018·16 cites·20 claims
- 1093US9439896B2Quinolines as FGFR kinase modulatorsASTEX THERAPEUTICS LTD·Filed 2012·Granted Sep 13, 2016·22 cites·20 claims
- 1193US9290478B2Substituted quinoxalines as FGFR kinase inhibitorsSAXTY GORDON·Filed 2011·Granted Mar 22, 2016·25 cites·20 claims
- 1292US11001575B1Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2019·Granted May 11, 2021·4 cites·26 claims
- 1392US10052320B2Substituted quinoxalines as FGFR kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2016·Granted Aug 21, 2018·11 cites·20 claims
- 1492US10045982B2Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2016·Granted Aug 14, 2018·11 cites·33 claims
- 1592US10039759B2Quinolines as FGFR kinase modulatorsASTEX THERAPEUTICS LTD·Filed 2016·Granted Aug 7, 2018·11 cites·21 claims
- 1692US8895745B2Bicyclic heterocyclic compounds as FGFR inhibitorsBERDINI VALERIO·Filed 2007·Granted Nov 25, 2014·33 cites·20 claims
- 1791US10457669B2Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2016·Granted Oct 29, 2019·5 cites·25 claims
- 1891US8110573B2Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinasesBERDINI VALERIO·Filed 2005·Granted Feb 7, 2012·9 cites·17 claims
- 1990US10519137B2Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2017·Granted Dec 31, 2019·6 cites·18 claims
- 2090US8071614B2Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitorsSAXTY GORDON·Filed 2008·Granted Dec 6, 2011·16 cites·12 claims
- 2190US7977477B2Benzimidazole derivatives and their use as protein kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2004·Granted Jul 12, 2011·35 cites·23 claims
- 2289US8481531B2Bicyclic heterocyclyl derivatives as FGFR kinase inhibitors for therapeutic useSAXTY GORDON·Filed 2010·Granted Jul 9, 2013·9 cites·20 claims
- 2388US7825140B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsASTEX THERAPEUTICS LTD·Filed 2007·Granted Nov 2, 2010·7 cites·19 claims
- 2488US7745638B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsASTEX THERAPEUTICS LTD·Filed 2007·Granted Jun 29, 2010·8 cites·23 claims
- 2587US8131527B1FGFR pharmacophore compoundsSAXTY GORDON·Filed 2007·Granted Mar 6, 2012·17 cites·47 claims
- 2687US8076354B2Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitorsSAXTY GORDON·Filed 2008·Granted Dec 13, 2011·9 cites·13 claims
- 2785US10272087B2Pteridines as FGFR inhibitorsASTEX THERAPEUTICS LTD·Filed 2016·Granted Apr 30, 2019·5 cites·21 claims
- 2885US8080666B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsBERDINI VALERIO·Filed 2010·Granted Dec 20, 2011·6 cites·19 claims
- 2984US8859582B2Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitorsSAXTY GORDON·Filed 2011·Granted Oct 14, 2014·7 cites·20 claims
- 3083US8513276B2Imidazo[1,2-a]pyridine compounds for use in treating cancerBERDINI VALERIO·Filed 2007·Granted Aug 20, 2013·8 cites·16 claims
- 3182US2024368136A1Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2023·Application pending·0 cites
- 3280US8546407B2Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitorsBERDINI VALERIO·Filed 2005·Granted Oct 1, 2013·4 cites·18 claims
- 3379US8778936B2Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinasesBERDINI VALERIO·Filed 2011·Granted Jul 15, 2014·2 cites·20 claims
- 3477US8779147B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsBERDINI VALERIO·Filed 2011·Granted Jul 15, 2014·2 cites·14 claims
- 3577US2022135544A1Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 3676US9006430B2Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as proteinASTEX THERAPEUTICS LTD·Filed 2014·Granted Apr 14, 2015·2 cites·20 claims
- 3776US8691806B2Pyrazole derivatives as protein kinase modulatorsBERDINI VALERIO·Filed 2012·Granted Apr 8, 2014·2 cites·20 claims
- 3875US8809336B2Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitorsASTEX THERAPEUTICS LTD·Filed 2013·Granted Aug 19, 2014·2 cites·13 claims
- 3973US8796244B2Imidazopyridine derivatives as inhibitors of receptor tyrosine kinasesBERDINI VALERIO·Filed 2009·Granted Aug 5, 2014·2 cites·21 claims
- 4073US8247576B2Pyrazole derivatives as protein kinase modulatorsBERDINI VALERIO·Filed 2004·Granted Aug 21, 2012·5 cites·8 claims
- 4172US11939321B2Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2021·Granted Mar 26, 2024·0 cites·28 claims
- 4268US2020131153A1Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 4365US9051278B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsASTEX THERAPEUTICS LTD·Filed 2014·Granted Jun 9, 2015·0 cites·24 claims
- 4462US9283226B2Pyrazole derivatives as protein kinase modulatorsASTEX THERAPEUTICS LTD·Filed 2014·Granted Mar 15, 2016·0 cites·20 claims
- 4556US2008045522A1Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cellsDOMPE PHA R MA SPA RES & MFG·Filed 2007·Application pending·0 cites
- 4655US2014010892A1Benzimidazole derivatives and their use as protein kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2013·Application pending·0 cites
- 4754US9493402B2Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cellsDOMPÉ S P A·Filed 2012·Granted Nov 15, 2016·0 cites·4 claims
- 4853US2016250187A1Pyrazole derivatives as protein kinase modulatorsASTEX THERAPEUTICS LTD·Filed 2016·Application pending·0 cites
- 4952US2008194562A1Pyrazole Derivatives For The Inhibition Of Cdk's And Gsk'sASTEX THERAPEUTICS LTD·Filed 2006·Application pending·0 cites
- 5052US2008306069A1Pyrazole Derivatives for the Inhibition of CDK'S and GSK'SASTEX THERAPEUTICS LTD·Filed 2006·Application pending·0 cites
Showing the top 50 of 63 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →